Page last updated: 2024-10-31

molsidomine and Dyskinesia Syndromes

molsidomine has been researched along with Dyskinesia Syndromes in 1 studies

Molsidomine: A morpholinyl sydnone imine ethyl ester, having a nitrogen in place of the keto oxygen. It acts as NITRIC OXIDE DONORS and is a vasodilator that has been used in ANGINA PECTORIS.
molsidomine : A member of the class of oxadiazoles that is 1,2,3-oxadiazole substituted by morpholin-4-yl and (ethoxycarbonyl)azanidyl groups at positions 3 and 5, respectively. It is used as a vasodilator drug for the treatment of myocardial ischemic syndrome and congestive heart failure.

Research Excerpts

ExcerptRelevanceReference
" Chronic administration of haloperidol (1 mg/kg i."1.35Co-administration of nitric oxide (NO) donors prevents haloperidol-induced orofacial dyskinesia, oxidative damage and change in striatal dopamine levels. ( Bishnoi, M; Chopra, K; Kulkarni, SK, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bishnoi, M1
Chopra, K1
Kulkarni, SK1

Other Studies

1 other study available for molsidomine and Dyskinesia Syndromes

ArticleYear
Co-administration of nitric oxide (NO) donors prevents haloperidol-induced orofacial dyskinesia, oxidative damage and change in striatal dopamine levels.
    Pharmacology, biochemistry, and behavior, 2009, Volume: 91, Issue:3

    Topics: Animals; Antipsychotic Agents; Arginine; Chromatography, High Pressure Liquid; Citrulline; Dopamine;

2009